Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125184102 | 12518410 | 2 | F | 20160407 | 20160725 | 20160630 | 20160728 | EXP | GB-002147023-PHFR2016GB002801 | GB-GALDERMA-GB16004331 | GALDERMA | 41.00 | YR | F | Y | 0.00000 | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125184102 | 12518410 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | U | 50783 | |||||||||||
| 125184102 | 12518410 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | 0 | ||||||||||||
| 125184102 | 12518410 | 3 | SS | TYVERB | LAPATINIB | 1 | 0 | ||||||||||||
| 125184102 | 12518410 | 4 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | INJECTION | ||||||||||
| 125184102 | 12518410 | 5 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 0 | INJECTION | ||||||||||
| 125184102 | 12518410 | 6 | SS | LOPERAMIDE | LOPERAMIDE | 1 | 0 | ||||||||||||
| 125184102 | 12518410 | 7 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125184102 | 12518410 | 1 | Acne |
| 125184102 | 12518410 | 2 | Product used for unknown indication |
| 125184102 | 12518410 | 3 | Product used for unknown indication |
| 125184102 | 12518410 | 4 | Product used for unknown indication |
| 125184102 | 12518410 | 5 | Product used for unknown indication |
| 125184102 | 12518410 | 6 | Product used for unknown indication |
| 125184102 | 12518410 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125184102 | 12518410 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125184102 | 12518410 | Abasia | |
| 125184102 | 12518410 | Acne | |
| 125184102 | 12518410 | Anxiety | |
| 125184102 | 12518410 | Contusion | |
| 125184102 | 12518410 | Depression | |
| 125184102 | 12518410 | Diarrhoea | |
| 125184102 | 12518410 | Dyspnoea | |
| 125184102 | 12518410 | Eating disorder | |
| 125184102 | 12518410 | Fatigue | |
| 125184102 | 12518410 | Gastritis | |
| 125184102 | 12518410 | Headache | |
| 125184102 | 12518410 | Inflammatory pain | |
| 125184102 | 12518410 | Insomnia | |
| 125184102 | 12518410 | Intentional product use issue | |
| 125184102 | 12518410 | Malaise | |
| 125184102 | 12518410 | Muscle spasms | |
| 125184102 | 12518410 | Onychalgia | |
| 125184102 | 12518410 | Oropharyngeal pain | |
| 125184102 | 12518410 | Pain in extremity | |
| 125184102 | 12518410 | Peripheral swelling | |
| 125184102 | 12518410 | Plantar erythema | |
| 125184102 | 12518410 | Pruritus | |
| 125184102 | 12518410 | Speech disorder | |
| 125184102 | 12518410 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125184102 | 12518410 | 1 | 20160324 | 0 |